DIFFUSION PHARMACEUTICALS IN's ticker is DFFN and the CUSIP is 253748206. A total of 20 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,000 | -16.7% | 12,350 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | -14.3% | 12,350 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $7,000 | -53.3% | 12,350 | 0.0% | 0.00% | -75.0% |
| Q4 2017 | $15,000 | -28.6% | 12,350 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $21,000 | -27.6% | 12,350 | 0.0% | 0.01% | -33.3% |
| Q2 2017 | $29,000 | – | 12,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Swift Run Capital | 2,508,017 | $1,369,000 | 0.98% |
| WHITTIER TRUST CO OF NEVADA INC | 135,551 | $73,000 | 0.01% |
| Virtu Financial LLC | 25,335 | $14,000 | 0.00% |
| Signature Financial Management, Inc. | 12,350 | $7,000 | 0.00% |
| IHT Wealth Management, LLC | 3,800 | $2,000 | 0.00% |
| THOMPSON SIEGEL & WALMSLEY LLC | 2,000 | $1,000 | 0.00% |
| Smithfield Trust Co | 2,052 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 904,815 | $494,000 | 0.00% |
| ROYAL BANK OF CANADA | 1 | $0 | 0.00% |
| St. Johns Investment Management Company, LLC | 23 | $0 | 0.00% |